back to top
Wednesday, 26 November, 2025
HomeNews UpdateG20 leaders pledge $11bn to tackle deadly diseases

G20 leaders pledge $11bn to tackle deadly diseases

Several nations have raised $11.34bn for the Global Fund to fight Aids, TB and Malaria, with President Cyril Ramaphosa saying that $36m would be coming from the South African government and business community, reports News24.

This was announced in his capacity as the fund’s co-chair for 2025 at the 8th Global Fund replenishment summit in Sandton last Friday.

Ramaphosa, who delivered the keynote address, said the replenishment summit took place “at a time when multilateralism is sorely tested”.

He described the event as a milestone for global health, saying that building resilient health systems, scaling up local manufacturing of medicines, diagnostics, and therapeutics, and securing sustainable financing were vital for both social and economic development.

“Without a healthy population, nations cannot prosper. It is… essential we close gaps in access to medicines, diagnostics, and therapeutics, and financing as well, so that every country can protect its people and achieve health equity,” he added.

Ramaphosa said it had been a privilege to co-host the summit over the past year alongside the UK and its Prime Minister Sir Keir Starmer.

Starmer said it was the first time partners from the Global North and South had co-chaired the Global Fund, while German Vice Chancellor and Federal Minister of Finance Lars Klingbeil said the G20 had proven its merit over and over again “as a format where most urgent global challenges of our time can be discussed worldwide”.

 

News24 article – G20 | World leaders pledge $11bn at global health summit to tackle deadly diseases (Restricted access)

 

See more from MedicalBrief archives:

 

Motsoaledi urges commitment to UHC at G20 meeting

 

African self-reliance punted at key public health conference

 

Global Fund raises $14bn for next three years

MedicalBrief — our free weekly e-newsletter

We'd appreciate as much information as possible, however only an email address is required.